2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

904. Outcomes Research: Hemoglobinopathies: Poster II

Program: Poster Abstract Session
Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Treatment Considerations, Supportive Care, Biological Therapies, Transfusion, Women’s Health, Adverse Events, Clinical Practice (Health Services and Quality), Health Economics, Quality of Care, Diseases, Bleeding and Clotting, Thromboembolism, Hemoglobinopathies, Sickle Cell Disease, Sickle Cell Trait, Thalassemia, Research, Clinical Research, Epidemiology, Health Outcomes Research, Health Disparities Research, Patient-Reported Outcomes, Real-World Evidence, Registries, Study Population, Human, Adult, Elderly, Pediatric, Young Adult
PAPER

4439 Usual gait speed predicts future disability in adults with sickle cell disease

Charity I. Oyedeji, MD, Rania E Mohamed, BS2, Teagan Callaway, BS3, Li Lin4, Tamara Poole5, Francyess Denis Oliva, MD6, Bryce B. Reeve, PhD7, John Joseph Strouse, MD, PhD8
1 Duke University School of Medicine, Durham, North Carolina, United States
2 Duke University School of Medicine, Durham, North Carolina, United States
3 Duke University School of Medicine, Durham, North Carolina, United States
4 Duke University, Durham, North Carolina, United States
5 Duke University, Durham, North Carolina, United States
6 Duke University School of Medicine, Durham, North Carolina, United States
7 Duke University, Durham, North Carolina, United States
8 Duke University School of Medicine, Durham, North Carolina, United States

BACKGROUND
Adults with sickle cell disease (SCD) experience accelerated functional decline. Usual gait speed, an easily administered measure of mobility, strongly predicts of overall health and disability in community-dwelling older adults. Impairment in ≥ 1 Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL) is a well-established definition of disability that predicts cognitive decline, hospitalizations, loss of independence, and mortality. Predictive measures like gait speed offer an opportunity to identify at-risk individuals early and intervene before function is lost. However, the predictive validity of gait speed has not been established in people with SCD. This study examined whether gait speed predicts incident ADL/IADL disability in adults with SCD.

METHODS
We conducted a longitudinal study in adults with SCD at a single academic sickle cell center to assess the predictive validity of gait speed as part of the Sickle Cell Disease Functional Assessment Validation and Refinement (SILVR) parent study. We excluded wheelchair-bound or moderate-severely cognitively impaired patients. Participants completed the 14-item Older Americans Resources and Sources (OARS) ADL/IADL survey and had usual gait speed measured on a 15-foot walking course in a hallway in clinic at steady-state during baseline and annual visits (a subset also at 6 months) for up to 45 months.

Participants with ≥ 1 impairment on the OARS ADL/IADL survey at baseline were excluded from the time-to-event analysis. The primary outcome event was incident disability, defined as the first occurrence of  ≥ 1 ADL/IADL impairment. Time-to-event was calculated from the baseline assessment date to the first occurrence of ADL/IADL disability. Participants who died before developing disability were censored at the date of death, and those remaining disability-free were censored at their last available follow-up assessment. A cause-specific Cox proportional hazards regression model was used to evaluate the association between baseline gait speed and risk of incident disability. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated. Kaplan-Meier methods estimated disability-free survival with survival curves compared across tertiles of baseline gait speed using the log-rank test.

RESULTS
Of the 164 participants, 21 had missing ADL/IADL data and 54 (33%) had ADL/IADL disability at baseline. Participants with disability at baseline were older (mean age 48 SD 13; range 22-72), 74% female, 52% severe SCD genotype (SS/Sβ0) with mean gait speed of 1.05 m/s (SD 0.26).

The 89 participants contributing valid observations to the Kaplan-Meier analysis had a mean age of 43 (SD 13.5; range 19-77), 57% female, and 66% SS/Sβ0.

During follow-up, 20 participants (23%) experienced incident disability. Baseline gait speed averaged 1.10 m/s (SD 0.26; median 1.03; range 0.80-1.78) among those who developed disability versus 1.20 m/s (SD 0.22; median 1.22; range 0.68-1.78) among those who did not.

Cox proportional hazards analysis showed that baseline gait speed was significantly associated with incident disability, and faster gait speed was associated with a substantially lower risk of disability (p = 0.048). Specifically, each 0.1 m/s increase in baseline gait speed was associated with a 19.4% lower hazard of disability (HR = 0.806, 95% CI: 0.651–0.998).

Kaplan-Meier curves showed greater disability-free survival among participants with faster baseline gait speed. Incident disability occurred in 44% of participants in the slowest gait speed tertile (≤ 1.09 m/s) compared with 11% and 19% in the middle (1.10-1.25) and fastest (> 1.25) tertiles, respectively. Survival distributions differed across tertiles (log-rank test p=0.008). Individuals in the slowest gait speed tertile had a mean age of 46 (SD 15), 63% SS/Sβ0, and 59% female; corresponding values in the middle/fastest tertiles were age 44 (SD 12), 69% SS/Sβ0, and 54% female.

CONCLUSION
This study provides the first evidence that usual gait speed predicts future ADL/IADL disability in adults with SCD, with each 0.1 m/s increase in gait speed associated with a 19.4% lower risk of disability. These findings establish gait speed as a simple tool for identifying individuals with SCD at risk for disability. Incorporating gait speed into routine care may allow for earlier identification of at-risk individuals, creating opportunities for timely intervention to preserve independence in adults living with SCD.

Charity I. Oyedeji, MD: No relevant conflicts of interest to declare.